Background: Different methods for intracranial electrode recording have various advantages and disadvantages, and controversy exists regarding the complications of stereoelectroencephalography (SEEG) and subdural EEG. Objective: The purpose of this study was to determine the efficacy and safety of SEEG by comparing it with subdural EEG. Methods: Data from 100 patients who underwent SEEG (n = 48) and subdural EEG (n = 52) to evaluate the epileptogenic zone were collected from June 2011 to June 2015. The evaluation results, surgical outcomes, and complications were compared. Results: No significant differences were noted between the SEEG and subdural EEG groups in identifying the epileptogenic zone or undergoing epileptic surgery. Of the 88 patients who underwent epilepsy surgery after assessment, 59.5% in the SEEG group and 52.2% in the subdural EEG group became seizure free. No significant differences in postoperative seizure control or intelligence improvement were noted. The overall complication rate in SEEG patients (8/48; 16.7%) was lower than that in subdural EEG patients (13/52; 25%), particularly for hemorrhage and infection (4.2 vs. 17.3%, p < 0.05). Conclusions: This retrospective review indicates that SEEG has low associated complications, particularly regarding hemorrhage and infection. SEEG is a safe and effective method for intracranial monitoring.

Enatsu R, Bulacio J, Najm I, Wyllie E, So NK, Nair DR, Foldvary-Schaefer N, Bingaman W, Gonzalez-Martinez J: Combining stereo-electroencephalography and subdural electrodes in the diagnosis and treatment of medically intractable epilepsy. J Clin Neurosci 2014;21:1441-1445.
Delev D, Send K, Malter M, Ormond DR, Parpaley Y, von Lehe M, Schramm J, Grote A: Role of subdural interhemispheric electrodes in presurgical evaluation of epilepsy patients. World Neurosurg 2015;84:1719.e1-1725.e1.
Mehta AD, Labar D, Dean A, Harden C, Hosain S, Pak J, Marks D, Schwartz TH: Frameless stereotactic placement of depth electrodes in epilepsy surgery. J Neurosurg 2005;102:1040-1045.
Barbaro NM: Stereoelectroencephalography using computerized tomography- or magnetic resonance imaging-guided electrode implantation. J Neurosurg 2006;104:480-482.
Centeno RS, Yacubian EM, Caboclo LO, Júnior HC, Cavalheiro S: Intracranial depth electrodes implantation in the era of image-guided surgery. Arq Neuropsiquiatr 2011;69:693-698.
Cossu M, Cardinale F, Castana L, Nobili L, Sartori I, Lo Russo G: Stereo-EEG in children. Childs Nerv Syst 2006;22:766-778.
Arya R, Mangano FT, Horn PS, Holland KD, Rose DF, Glauser TA: Adverse events related to extraoperative invasive EEG monitoring with subdural grid electrodes: a systematic review and meta-analysis. Epilepsia 2013;54:828-839.
Nair DR, Burgess R, McIntyre CC, Lüders H: Chronic subdural electrodes in the management of epilepsy. Clin Neurophysiol 2008;119:11-28.
McGonigal A, Bartolomei F, Régis J, Guye M, Gavaret M, Trébuchon-Da Fonseca A, Dufour H, Figarella-Branger D, Girard N, Péragut JC, Chauvel P: Stereoelectroencephalography in presurgical assessment of MRI-negative epilepsy. Brain 2007;130:3169-3183.
MacDougall KW, Burneo JG, McLachlan RS, Steven DA: Outcome of epilepsy surgery in patients investigated with subdural electrodes. Epilepsy Res 2009;85:235-242.
Dylgjeri S, Taussig D, Chipaux M, Lebas A, Fohlen M, Bulteau C, Ternier J, Ferrand- Sorbets S, Delalande O, Isnard J, Dorfmüller G: Insular and insulo-opercular epilepsy in childhood: an SEEG study. Seizure 2014;23:300-308.
Cossu M, Cardinale F, Colombo N, Mai R, Nobili L, Sartori I, Lo Russo G: Stereoelectroencephalography in the presurgical evaluation of children with drug-resistant focal epilepsy. J Neurosurg 2005;103:333-343.
Varotto G, Tassi L, Franceschetti S, Spreafico R, Panzica F: Epileptogenic networks of type II focal cortical dysplasia: a stereo-EEG study. Neuroimage 2012;61:591-598.
Murphy MA, O'Brien TJ, Cook MJ: Insertion of depth electrodes with or without subdural grids using frameless stereotactic guidance systems - technique and outcome. Br J Neurosurg 2002;16:119-125.
Vadera S, Mullin J, Bulacio J, Najm I, Bingaman W, Gonzalez-Martinez J: Stereoelectroencephalography following subdural grid placement for difficult to localize epilepsy. Neurosurgery 2013;72:723-729.
McGonigal A, Gavaret M, Da Fonseca AT, Guye M, Scavarda D, Villeneuve N, Régis J, Bartolomei F, Chauvel P: MRI-negative prefrontal epilepsy due to cortical dysplasia explored by stereoelectroencephalography (SEEG). Epileptic Disord 2008;10:330-338.
Lee WS, Lee JK, Lee SA, Kang JK, Ko TS: Complications and results of subdural grid electrode implantation in epilepsy surgery. Surg Neurol 2000;54:346-351.
Van Gompel JJ, Worrell GA, Bell ML, Patrick TA, Cascino GD, Raffel C, Marsh WR, Meyer FB: Intracranial electroencephalography with subdural grid electrodes: techniques, complications, and outcomes. Neurosurgery 2008;63:498-505.
Wong CH, Birkett J, Byth K, Dexter M, Somerville E, Gill D, Chaseling R, Fearnside M, Bleasel A: Risk factors for complications during intracranial electrode recording in presurgical evaluation of drug resistant partial epilepsy. Acta Neurochir (Wien) 2009;151:37-50.
Wiggins GC, Elisevich K, Smith BJ: Morbidity and infection in combined subdural grid and strip electrode investigation for intractable epilepsy. Epilepsy Res 1999;37:73-80.
Sperling MR: Clinical challenges in invasive monitoring in epilepsy surgery. Epilepsia 1997;38(suppl 4):S6-S12.
De Almeida AN, Olivier A, Quesney F, Dubeau F, Savard G, Andermann F: Efficacy of and morbidity associated with stereoelectroencephalography using computerized tomography- or magnetic resonance imaging-guided electrode implantation. J Neurosurg 2006;104:483-487.
Hedegärd E, Bjellvi J, Edelvik A, Rydenhag B, Flink R, Malmgren K: Complications to invasive epilepsy surgery workup with subdural and depth electrodes: a prospective population-based observational study. J Neurol Neurosurg Psychiatry 2014;85:716-720.
Cardinale F, Cossu M, Castana L, Casaceli G, Schiariti MP, Miserocchi A, Fuschillo D, Moscato A, Caborni C, Arnulfo G, Lo Russo G: Stereoelectroencephalography: surgical methodology, safety, and stereotactic application accuracy in 500 procedures. Neurosurgery 2013;72:353-366.
Guenot M, Isnard J, Ryvlin P, Fischer C, Ostrowsky K, Mauguiere F, Sindou M: Neurophysiological monitoring for epilepsy surgery: the Talairach SEEG method - stereoelectroencephalography. Indications, results, complications and therapeutic applications in a series of 100 consecutive cases. Stereotact Funct Neurosurg 2001;77:29-32.
Serra C, Huppertz HJ, Kockro RA, Grunwald T, Bozinov O, Krayenbühl N, Bernays RL: Rapid and accurate anatomical localization of implanted subdural electrodes in a virtual reality environment. J Neurol Surg A Cent Eur Neurosurg 2013;74:175-182.
Widmann G, Schullian P, Ortler M, Bale R: Frameless stereotactic targeting devices: technical features, targeting errors and clinical results. Int J Med Robot 2012;8:1-16.
Kahane P, Landré E, Minotti L, Francione S, Ryvlin P: The Bancaud and Talairach view on the epileptogenic zone: a working hypothesis. Epileptic Disord 2006;8(suppl 2):S16-S26.
Cossu M, Cardinale F, Castana L, Citterio A, Francione S, Tassi L, Benabid AL, Lo Russo G: Stereoelectroencephalography in the presurgical evaluation of focal epilepsy: a retrospective analysis of 215 procedures. Neurosurgery 2005;57:706-718.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.